(Q34603889)

English

A meta-analysis of randomized controlled trials comparing chemotherapy plus bevacizumab with chemotherapy alone in metastatic colorectal cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

0 references

A meta-analysis of randomized controlled trials comparing chemotherapy plus bevacizumab with chemotherapy alone in metastatic colorectal cancer (English)

1 reference

Europe PubMed Central

3 August 2017

0 references

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

author name string

Yunfei Cao

1

1 reference

Europe PubMed Central

3 August 2017

Aihua Tan

2

1 reference

Europe PubMed Central

3 August 2017

Feng Gao

3

1 reference

Europe PubMed Central

3 August 2017

Lidan Liu

4

1 reference

Europe PubMed Central

3 August 2017

Cun Liao

5

1 reference

Europe PubMed Central

3 August 2017

Zengnan Mo

6

1 reference

Europe PubMed Central

3 August 2017

publication date

30 January 2009

1 reference

Europe PubMed Central

3 August 2017

International Journal of Colorectal Disease

1 reference

Europe PubMed Central

3 August 2017

24

1 reference

Europe PubMed Central

3 August 2017

6

1 reference

Europe PubMed Central

3 August 2017

677-685

1 reference

Europe PubMed Central

3 August 2017

https://scigraph.springernature.com/pub.10.1007/s00384-009-0655-9

0 references

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

1 reference

https://api.crossref.org/works/10.1007%2FS00384-009-0655-9

21 January 2018

Systematic Reviews in Health Care

1 reference

https://api.crossref.org/works/10.1007%2FS00384-009-0655-9

21 January 2018

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Efficacy of Avastin in combination with irinotecan for metastatic colorectal cancer]

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterisation and clinical management of CPT-11 (irinotecan)-induced adverse events: the European perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biology of angiogenesis in tumors of the gastrointestinal tract

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response rate or time to progression as predictors of survival in trials of metastatic colorectal cancer or non-small-cell lung cancer: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of vascular endothelial growth factor-A expression, thrombospondin-2 expression, and microvessel density on the treatment effect of bevacizumab in metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurotoxicity From Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: NSABP C-07

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure. CPT-11 F205, F220, F221 and V222 study groups

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Managing patients treated with bevacizumab combination therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Palliative chemotherapy for advanced or metastatic colorectal cancer. Colorectal Meta-analysis Collaboration

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer statistics, 2008

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VEGF receptor signaling in tumor angiogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular and biological properties of vascular endothelial growth factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating D-dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro procoagulant activity induced in endothelial cells by chemotherapy and antiangiogenic drug combinations: modulation by lower-dose chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CPT-11 in the treatment of colorectal cancer: clinical efficacy and safety profile.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19184059

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00384-009-0655-9

1 reference

Europe PubMed Central

3 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34603889&oldid=1641896238"